FOLH1 and hepatocellular carcinoma: Tolkach et al. found that the majority of hepatocellular carcinomas show high levels of PSMA expression on the tumor neovasculature (89.9% of tumors) and on canalicular membrane of the tumor cells (41.1% of the tumors) [23].